There are other forms of bias in these datasets including channeling (e.g., the prescribing pattern depends on a patient characteristic (particularly diabetes or obesity) that is a PDAC risk factor), detection (e.g., overreporting due to additional testing to rule out a suspected adverse event (e.g., imaging triggered by pancreas enzyme elevations)), and Weber effect (initial increase in event reporting shortly after drug launch) 49
Mudit Sabharwal notes: For patients over 65 at Dharma Diabetes Clinics, we start with lower doses, check more often, and always pair GLP-1s with protein goals and strength training to protect muscle. Who Should NOT Take GLP-1 Drugs: BMI and Weight Rules Who should not take GLP-1 drugs for weight loss
Write a Review Rating Benefits Increased Energy Levels L-Carnitine converts stored fats into energy, providing a sustainable energy source for improved vitality
For chronic weight management , coverage depends on your specific insurance plan and whether the medication has FDA approval for weight loss (e.g., Wegovy, Zepbound) and if your plan includes weight loss medications